Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
rAd5-S
Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
rAd26-S
Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
Azvudine
Potential treatment - clinical evidence Experimental Antiviral Jul/14/2020
WIV04 strain vaccine
Potential treatment - clinical evidence Experimental Vaccine Aug/13/2020
CoronaVac
Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021
Thymosin α1
Potential treatment - clinical evidence Experimental Antiviral Oct/31/2020
Ad5-nCoV
Potential treatment - clinical evidence Experimental Vaccine Aug/14/2020
Zofin
Potential treatment - clinical evidence Experimental Other treatment Mar/17/2021
CIGB-258
Potential treatment - clinical evidence Experimental Other treatment Jun/02/2020
Lenzilumab
Potential treatment - clinical evidence Experimental Other treatment Nov/01/2020
FX06
Potential treatment - clinical evidence Experimental Other treatment Sep/24/2020
Human amnionic fluid
Potential treatment - clinical evidence Experimental Other treatment Jan/22/2021
Bamlanivimab
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
EXO-CD24
Potential treatment - clinical evidence Experimental Other treatment Jul/13/2022
CC12.1
Potential treatment - pre-clinical evidence Experimental Antiviral
mAb 222
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-55
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
COVA1-16
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
mAb Beta-29
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022